DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Brainstorm Cell Therapeutics Inc. (BCLI)
« Back to company indexBCLI Chatter Timeline
Stock Ticker for BCLI
Most Active Tweeters for BCLI
| User | Tweets |
|---|---|
| @AmericanBanking | 3 |
| @dakotafinancial | 3 |
| @TheMarketsDaily | 2 |
| @AHimar33 | 2 |
| @WeekHerald | 2 |
Recent Tweets for BCLI
 |
@TranscriptDaily Zacks: Brokerages Set $12.67 Target Price for Brainstorm Cell Therapeutics Inc $BCLI https://t.co/aKlgw4c3k5 October 20th 2019, 7:10pm |
 |
@registrarjourn Zacks: Brokerages Set $12.67 Price Target for Brainstorm Cell Therapeutics Inc $BCLI https://t.co/Z0FMbnmmux October 20th 2019, 7:10pm |
 |
@EnterpriseLeade Zacks: Brokerages Set $12.67 Price Target for Brainstorm Cell Therapeutics Inc $BCLI https://t.co/WRcsZjsynC October 20th 2019, 7:10pm |
 |
@WeekHerald Brainstorm Cell Therapeutics Inc $BCLI Given Average Rating of “Strong Buy” by Brokerages https://t.co/PIqNW3WJ25 October 18th 2019, 7:10am |
 |
@OlympiaReport Brainstorm Cell Therapeutics Inc $BCLI Given Average Rating of “Strong Buy” by Analysts https://t.co/QY5tQu9j4Q October 18th 2019, 7:10am |
 |
@stocknewstimes Brainstorm Cell Therapeutics Inc $BCLI Short Interest Update https://t.co/7zaSOU3cZ6 October 17th 2019, 9:10am |
 |
@TheMarketsDaily Brainstorm Cell Therapeutics Inc $BCLI Short Interest Update https://t.co/4J6fcxTAVF October 17th 2019, 9:10am |
 |
@dakotafinancial Brainstorm Cell Therapeutics Inc $BCLI Short Interest Update https://t.co/7HmPedZOLI October 15th 2019, 6:10am |
 |
@AmericanBanking Brainstorm Cell Therapeutics Inc $BCLI Short Interest Update https://t.co/AVQo5b9twz #stocks October 15th 2019, 6:10am |
 |
@macondailynews Brainstorm Cell Therapeutics Inc $BCLI Short Interest Update https://t.co/jHbpiZKUp0 October 15th 2019, 6:10am |
|
@WeekHerald Brainstorm Cell Therapeutics $BCLI PT Set at $9.00 by Maxim Group https://t.co/isvncJv99o October 15th 2019, 3:10am |
|
@AmericanBanking Brokerages Expect Brainstorm Cell Therapeutics Inc $BCLI to Post -$0.14 EPS https://t.co/ZFiUfl2SsZ #stocks October 15th 2019, 3:10am |
|
@dakotafinancial Zacks: Brokerages Set $12.67 Target Price for Brainstorm Cell Therapeutics Inc $BCLI https://t.co/Pg8VAHep6v October 15th 2019, 3:10am |
|
@TheMarketsDaily Maxim Group Analysts Give Brainstorm Cell Therapeutics $BCLI a $9.00 Price Target https://t.co/WAbVXQrVef October 15th 2019, 2:10am |
|
@stocknewstimes Maxim Group Analysts Give Brainstorm Cell Therapeutics $BCLI a $9.00 Price Target https://t.co/lhKTKCbw91 October 15th 2019, 2:10am |
 |
@ledgerzette Brainstorm Cell Therapeutics $BCLI Given a $9.00 Price Target by Maxim Group Analysts https://t.co/ULL64PaPZC #stocks October 15th 2019, 1:10am |
 |
@intercooleronli Brainstorm Cell Therapeutics $BCLI Given a $9.00 Price Target by Maxim Group Analysts https://t.co/uV4SkWoCAB #investingnews October 15th 2019, 1:10am |
|
@dakotafinancial Maxim Group Reiterates “$9.00” Price Target for Brainstorm Cell Therapeutics $BCLI https://t.co/4ywAIo35M6 October 15th 2019, 1:10am |
 |
@ThisLincolnian Brainstorm Cell Therapeutics $BCLI Given a $9.00 Price Target by Maxim Group Analysts https://t.co/UovFwUEvRU October 15th 2019, 1:10am |
|
@AmericanBanking Brainstorm Cell Therapeutics $BCLI Given a $9.00 Price Target by Maxim Group Analysts https://t.co/xnnwAh3dn6 #stocks October 14th 2019, 4:10pm |
 |
@ConsumerFeed Maxim Group Analysts Give Brainstorm Cell Therapeutics $BCLI a $9.00 Price Target https://t.co/MfP1p9KR6U October 14th 2019, 3:10pm |
 |
@SwingTradeBot 200 DMA Support today: $BCLI ... https://t.co/LjP7KUcNnp October 14th 2019, 2:10pm |
 |
@HottestStockNow $BCLI 's NurOwn Phase 3 ALS Clinical Trial Now Fully Enrolled #BrainStorm #ALS https://t.co/SmA6sXDGiR October 12th 2019, 11:10am |
 |
@PabloAl71818691 RT @MaisaCorp: $BCLI NurOwn Late-Stage Trial of Motor Neuron Disease Fully Enrolled October 11th 2019, 6:10pm |
 |
@MaisaCorp $BCLI expect that all trial participants will complete planned study visits and assessments by October 2020 October 11th 2019, 4:10pm |
|
@MaisaCorp $BCLI NurOwn Late-Stage Trial of Motor Neuron Disease Fully Enrolled October 11th 2019, 4:10pm |
 |
@AHimar33 $BCLI For traders, market cap is only $80 million and the float is very small. Multiple X runner on good phase 3 results. #nurown October 11th 2019, 11:10am |
|
@AHimar33 $BCLI Big milestone for this little known biotech for ALS. Ph. 3 fully enrolled. The entire ALS community is watchi… https://t.co/s3NY5cpcah October 11th 2019, 11:10am |
|
@Cylebo What a milestone! #NurOwn @BrainstormCell #ALS @CIRMnews We need your continued support $BCLI support! https://t.co/b3a7VZ1uZ3 October 11th 2019, 8:10am |
 |
@Rafael60980545 RT @MarketCurrents: $BCLI - Enrollment completed in BrainStorm’s late-stage NurOwn study https://t.co/8xksFiEDIp October 11th 2019, 7:10am |
 |
@DavidBautz $BCLI completes enrollment in P3 trial of #NurOwn in #ALS. Results by Oct. 2020 https://t.co/cVR92vdleL October 11th 2019, 7:10am |
 |
@NewsToDesk $BCLI: Enrollment completed in BrainStorm’s late-stage NurOwn study: https://t.co/WSp4yg6BS4 October 11th 2019, 7:10am |
 |
@newsfilterio Enrollment completed in BrainStorm’s late-stage NurOwn study $BCLI https://t.co/vxKzFZE2ig October 11th 2019, 7:10am |
 |
@MarketCurrents $BCLI - Enrollment completed in BrainStorm’s late-stage NurOwn study https://t.co/8xksFiEDIp October 11th 2019, 7:10am |
|
@rrao111 Never give up! Peoples lives are at stake! Go. $BCLI https://t.co/0uckTfrVcm October 11th 2019, 7:10am |
 |
@fierro7676 #Nurown full enrollment $BCLI https://t.co/fR4Vrgq2gp October 11th 2019, 3:10am |
|
@newsfilterio BrainStorm’s NurOwn® Phase 3 ALS Clinical Trial Now Fully Enrolled $BCLI https://t.co/4jLvFteplj October 11th 2019, 1:10am |
 |
@StockTexts $BCLI BrainStorm’s NurOwn® Phase 3 ALS Clinical Trial Now Fully Enrolled Nasdaq:BCLI https://t.co/sNescKMMPz October 11th 2019, 1:10am |
 |
@ahighelevation $BCLI Topline Data from P3 #ALS Trial Likely in 3Q20 #biotech - https://t.co/sGBI6gjFtK https://t.co/wuaBtwIskj October 10th 2019, 11:10am |
 |
@PennyStockPlay1 BrainStorm Cell Therapeutics Inc. (NASDAQ: $BCLI), Announces Notice of US Patent Allowance for NurOwn® Cellular The… https://t.co/x2zXLryrRl October 9th 2019, 9:10am |
|
@MaisaCorp $BCLI received a notice of allowance for its NurOwn Cellular Therapeutic Technology Platform from the US Patent and Trademark Office. October 7th 2019, 4:10pm |
 |
@BlueBioNow $BCLI Enjoy the weekend everyone! Cheers! ???? 3.92 % change recently https://t.co/Me20K7pTq7 October 7th 2019, 4:10pm |
 |
@ZacksSmallCap Topline Data from P3 #ALS Trial Likely in 3Q20 $BCLI https://t.co/vVVDGocURV https://t.co/nLrZuElSKS October 7th 2019, 2:10pm |
|
@MarketCurrents $BCLI - Brainstorm up 1% on U.S. patent covering NurOwn https://t.co/a16jJ3OAcq October 7th 2019, 12:10pm |
 |
@StockNewsNow $BCLI BrainStorm Announces Notice of US Patent Allowance for NurOwn® Cellular Therapeutic Technology Platform https://t.co/gzoCXHbrGQ October 7th 2019, 12:10pm |
 |
@TowelieTrades RT stock_family: https://t.co/Omy7sgoEXz $BCLI ?Dump #Robinhood for #stockoptions: https://t.co/YWb0YTEzG0 ?… https://t.co/uXF3eTtHVX October 7th 2019, 9:10am |
 |
@ChartMill $BCLI is one of the better performing stocks in the Drugs industry. https://t.co/xQbmw5emNm https://t.co/JwTvTm4Ebe October 3rd 2019, 2:10pm |
 |
@smallcapwatch RT @ahighelevation: $BCLI Patient Enrollment Almost Complete in P3 #ALS Trial #smallcap https://t.co/baQ7fS7b2l https://t.co/z28Whsn5YK October 2nd 2019, 3:10pm |
|
@ahighelevation $BCLI Patient Enrollment Almost Complete in P3 #ALS Trial #smallcap https://t.co/baQ7fS7b2l https://t.co/z28Whsn5YK October 2nd 2019, 3:10pm |
 |
@Q8Honer RT @Cylebo: Very excited by newest recruitment to $BCLI. @BrainStormCell better positioned for pivotal phase 3 and even earlier #Nurown com… October 2nd 2019, 11:10am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.